Friday, January 23, 2009

Stem cells

Stem-cell research is en vogue — 25 years after scientists first isolated mouse embryonic stem cells, it is now possible to isolate and culture stem cells from embryos and adult tissues of many species, including humans. Despite the rapid progress in this field, several important questions in the areas of embryonic and adult stem-cell research still remain unanswered. What are the cellular and molecular mechanisms that underlie stem-cell renewal while conveying the potential to differentiate to different cell lineages? What combination of molecules confers differentiation to specific cell types? How can we isolate stem cells from different tissues? And how will knowledge of the mechanisms that underlie self-renewal and differentiation help us to develop patient-specific therapies?

In a Series of specially commissioned articles, Nature Reviews Molecular Cell Biology reports on the current hot and exciting topics in stem-cell research, discusses new technologies and resources to study stem cells and explores controversial issues, such as stem-cell ethics and funding.
Find more informations under:

Tuesday, January 20, 2009

Jurnal Club


Dear Dato'/Prof/ Assoc. Prof/ Dr/ colleagues,

I am pleased to invite all of you to IMMB journal club session that will be held as follow:


Topic : The Impact of Next Generation Sequencing Technology on Genetics
Presenter : Mr. Muhamad Alif bin Che Nordin
Chairperson : Mrs. Suhaila Abd Muid
Venue : IMMB Meeting Room, Level 13, Block 5, S&T Building
Date : 21 January 2009, Wednesday
Time : 12.45 noon

All are welcome. Thank you


ZD

Wednesday, January 14, 2009

Drug Discovery & Development - January 12, 2009


Obesity Starts in the Head

Obesity is known to increase the risk of chronic disorders, such as type 2 diabetes. An international team of scientists with German participation through the Helmholtz Zentrum München identified six new obesity genes. Gene expression analyses have shown that all six genes are active in brain cells.

The international GIANT (Genetic Investigation of Anthropometric Parameters) consortium works on the discovery of obesity genes. So far, the scientists have analyzed two million DNA variations in 15 genome-wide association studies with a total of more than 32,000 participants. The hereby identified candidate genes were validated in 14 further studies including 59,000 participants. In addition to the FTO and MC4R genes already known, it was now possible for six more obesity genes to be identified: TMEM18, KCTD15, GNPDA2, SH2B1, MTCH2, and NEGR1.

Gene expression analyses have shown that all six genes are active in brain cells. Also the previously known two obesity genes, FTO and MC4R, show a similar expression pattern; in case of the MC4R gene, a genotype-dependant influence on the behavior of appetite is already established. Scientists of the German National Genome Research Network (NGFN), Prof. H.-Erich Wichmann and Dr. Iris Heid from the Helmholtz Zentrum München, Institute of Epidemiology, who lead the German participation of this consortium, emphasize: ‘Definitely, the two main causes for obesity are poor nutrition and lack of physical activity. But the biology of these genes suggests genetic factors underlying the different reaction of people to lifestyle and environmental conditions.’

With the exception of the SH2B1 gene, which plays a role in the leptin signalling and thus in the regulation of appetite, none of the other five genes was hitherto discussed as obesity genes. Iris Heid and her collegue Claudia Lamina from the Ludwigs-Maximilians-Universität München are enthused: ‘The purely statistical approach of the genome-wide association analysis can depict new aspects of the biology of weight regulation, which were previously unanticipated.’

As a next step, the scientists evaluate other anthropometric measures, in order to shed light on different aspects of obesity. In addition, they will expand and include further studies into their analysis as they have realized that the individual studies are all too small, and only by means of collaboration, is it possible to achieve further success here.

Release Date: January 8, 2009

Tuesday, January 13, 2009

Jurnal Club


Dear Dato'/Prof/ Assoc. Prof/ Dr/ colleagues,


I am pleased to invite all of you to our weekly IMMB journal club session that will be held as follow:


Title : Genetic Mapping in Human Diseases
Presenter : Dr. Hoh Boon Peng
Chairperson : Mrs. Rafezah Razali
Venue : IMMB Meeting Room, Level 13, Block 5, S&T Building
Date : 14 January 2009, Wednesday
Time : 12.45 noon

All are welcome and refreshment will be served starting from 12.15 noon.
Thank you

ZD

Tuesday, January 6, 2009

Educationational webpage from NPG

The Nature Publishing Group (NPG) has created an educational webpage where students and others can read up on genetics. I find this webpage very usefull.
Go have a look
Gabriele


NPG announces a free website for biology classes... Scitable by Nature Education

Scitable is designed to expand students' knowledge of genetics by providing expert, evidence-based content.
To learn more about this exciting, new educational product visit
www.nature.com/scitable/whatisscitable

Monday, January 5, 2009

Editorial
Nature Cell Biology 11, 1 (2008)

Published online: 10 December 2008 doi:10.1038/ncb0109-1

Credit where credit is due

Abstract
Citations are an important component in the assessment of academic performance. Yet, the growing literature, combined with format constraints of journals, encourage citation of reviews in preference to primary research. This diverts academic credit from the discoverer.
Introduction
Scientific research continues to accelerate, mirrored by unprecedented publication rates: PubMed contains over 18 million citations now. In many fields it is becoming increasingly difficult to cite the literature appropriately. As fields mature, they accumulate larger volumes of back literature and all too often, multiple papers report related findings. Both factors pose a challenge for comprehensive and systematic reference lists. Yet the format of papers in most journals, including NCB, has not changed significantly, encouraging selective or secondary literature citation.
The pressure on researchers is higher than ever before and many find themselves chronically short of time. A lamentable but largely unavoidable by-product of the cocktail of specialization, accelerated research activity and increased overall scientific output is that browsing the literature is on the decline, in favour of keyword-directed access to information. Search engines, such as PubMed and Google Scholar, do allow reliable access to specific information, and browsing is aided by text-comparison engines. Also, the information overload of increasingly specialized researchers has precipitated a rapid growth of the review literature. Reviews have replaced browsing as a means to stay abreast of scientific progress beyond one's area of specialization. The increased reliance on the review literature to access information has led to a tendency to cite reviews, rather than the underlying primary literature. Assuming the review is authoritative and comprehensive, this still removes the reader one or more steps from the relevant original work, and many will not have the time to trace the primary citation(s). Importantly, every paper that does not directly cite the initial report of a finding, takes away academic credit from the discoverer, often directly affecting his or her funding and career.
Even when citing the primary literature, there is evidence that authors, on occasion, simply transfer citations from other papers they have read. A fascinating estimate of the prevalence of this practice was provided by a study that measured the transmission of typographical errors in the 4,300 citations to a 1973 paper on condensed-matter physics, concluding that about 78% of the references were transcribed from other reference lists, rather than the original source article (Simkin, M.V. & Roychowdhury, V.P. Complex Syst. 14, 269; 2003; see also Nature 420, 594; 2002). If this applies to cell biology, it may point to a troublesome culture of cutting-and-pasting in preference to reading the primary literature. This may consequently inflate the citation of certain papers and distort the scientific record (see also Nature 423, 373–373; 2003). Needless to say, this journal requests that authors evaluate the paper cited, rather than take someone else's word for it. This is particularly important when writing reviews, which tend to set certain beliefs in stone.
In the last issue of NCB, 26% of all citations were to reviews (9.1 4.1 (s.d.) of 34.5, n = 11), compared with 21% in the inaugural issue of NCB in 1999 (8.3 3.9 of 40.2, n = 11). Notably, papers ranged between 11 and 52% in review citation rate. It is worth noting that reviews also contain a significant fraction of citations to other reviews (around 20% in a random sample of Nature Reviews articles). Two issues encourage review citation: 1) most journals have rather compact citation lists. Citing reviews often allows an author to 'kill several birds with one stone', and it is a technique to stay within restrictive citation limits. 2) ISI (Thomson Scientific) continues to lump together citations of primary research papers and reviews. This has had a major impact on researchers and indeed journals: it boosts cumulative citations of the former, while providing papers that tend to be well-cited for the latter to beef up journal impact factors. We have argued previously for a disambiguation of primary and review citations (October 2005 editorial).
An additional consideration is that in the current highly competitive world of cell biology, some researchers may be tempted to obfuscate the state of the field to enhance the apparent conceptual advance provided by their study. Rather than omitting a citation altogether, a less onerous approach may be to support a vague statement by citing a general review.
We aim to address this important issue in the two ways. First, we have increased the reference limits on our papers by 40%. In the 'Article' format, authors can now cite up to 70 references, rather than 50; for 'Letters', 40 instead of 30, and 20 references for 'Brief Communications'. Our 'Reviews' can now contain 140 instead of 100 references and 70 for 'Perspectives'. Second, we strongly encourage authors to cite the primary literature where appropriate. Clearly, citing reviews is the only effective way to provide background information on whole fields (for example, 'cell migration' or 'enzymology of the ubiquitin-proteasome system') or more focussed topics with a considerable literature (for example, 'role of ATM in the DNA damage response'). In fact, citing a review for this purpose is far more appropriate than a random selection of primary papers. However, where specific findings are concerned, references to the primary literature must be included (for example 'Ser 46 phosphorylation of p53 regulates apoptosis'). Needless to say, in many cases, such as the p53 example provided, the literature may be large, complex and indeed sometimes contradictory. Although previous discussion of a finding provides invaluable help in navigating the literature, it is the authors' responsibility to re-read the primary literature and to cite it where and as appropriate. If the primary report lies far back (say ten years) it is also often appropriate to cite a review that contextualizes the finding.
Although there can be no absolute rules for primary and secondary literature citation, we will monitor citations increasingly at the editorial level and request that authors adapt their citations where appropriate.
The EMBO Journal has just announced similar guidelines (EMBO J. doi: 10.1038/emboj.2008.250) and the hope is that these policies will encourage more direct and more accurate citation, which will enhance academic accountability. Give credit where credit is due.
Open-access editorials
Editorials in this journal will henceforth be freely accessible to anyone who has registered on the site
Roche - Nature Medicine

Translational Neuroscience Symposium 2009:
Autism and Other Developmental Brain Disorders

April 17-18, 2009 Roche Forum Buonas AG Switzerland
Attendance at this meeting is free on acceptance of application.
To apply and for more information visit www.nature.com/natureconferences/tns2009

Sunday, January 4, 2009

Journal Club













Dear Dato'/Prof/ Assoc. Prof/ Dr/ colleagues,

I am pleased to invite all of you to IMMB journal club session that will be held as follow:

Topic : In Vitro Antimicrobial Activity of Melastoma Malabathricum & Dicranopteris Lineris Extracts
Presenter : Ms Nurul Hamirah Kamsani
Chairperson : Ms. Nurul Ashikin Mohamed Rawi
Venue : IMMB Meeting Room, Level 13, Block 5, S&T Building
Date : 07 January 2009, Wednesday
Time : 12.45 noon

All are welcome and refreshment will be served starting from 12.15 noon at level 13.

ZD